Please login to the form below
influenza
This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.
Roche’s flu pill Xofluza gains EU approval
Xofluza offers patients the first novel mechanism of action for treating influenza approved in Europe in almost 20 years. ... found that the drug had a statistically significant prophylactic effect on influenza occurrences.
Latest news
-
Roche’s Xofluza pill wins FDA approval for post-exposure flu prevention
Xofluza was first approved by the FDA last year, and is available as a treatment for acute, uncomplicated influenza in people aged 12 years and older. ... We’re hopeful that reducing the burden of influenza may help to mitigate the strain on our
-
Sanofi’s quadrivalent flu vaccine Supemtek scores EU approval
Sanofi’s Supemtek is the now first and only recombinant influenza vaccine to be approved within the European Union. ... countries. “In the context of the COVID-19 pandemic, preventing influenza remains a public health priority,” said Thomas Triomphe
-
AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows
A number of studies have shown that a decreasing immune function caused by ageing results in a decreased immune response to vaccines, with this response previously observed for vaccines for influenza
-
Roche’s flu pill Xofluza moves closer towards EU approval
It is also approved in the US for the treatment of people who have a high risk of developing influenza-related complications. ... found that the drug had a statistically significant prophylactic effect on influenza occurrences.
-
Synairgen’s SNG001 advances into phase 3 COVID-19 trial
This might carry additional advantages of treating COVID19 when it occurs alongside infection by another respiratory virus such as influenza or Respiratory Syncytial Virus that may well be encountered in the
More from news
Approximately 19 fully matching, plus 205 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
worldwide, Dr Schaffner had a point to call attention to the dangers of influenza. ... As such, policymakers are continuing to stress the importance of planning for seasonal influenza circulation this winter.
-
‘It’s not about you, it’s about them’ – putting customer needs first in our communications
By Chris Finch. Pre-COVID-19, the H1N1 influenza pandemic of 1918 was the most severe global pandemic in modern history.
-
Effectively communicating in a public health crisis
In John M Barry’s 2009 Nature essay titled Pandemics: Avoiding the Mistakes of 1918, he said: ‘In the next influenza pandemic.
-
Biotech profile: Tom Evans, CEO, Vaccitech.
What are the shortcomings of current influenza vaccines, and why are new products needed? ... The outcome measurement is to decrease the amount of laboratory-confirmed influenza illness.
-
Case study: Break the flu cycle
76% of delegates felt more confident in their ability to manage the influenza vaccination. ... influenza infection, particularly among the more at-risk group of 65 years and over.
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors
During her ten-year career at Roche, Horning helped to bring 15 new medicines to patients in a range of diseases, including cancer, multiple sclerosis, influenza and blindness.
-
Germany's Ventaleon names biotech entrepeneur CEO
patients suffering from serious infections such as influenza to get better, faster.
-
Dr Michael Watson appointed as president of Valera
Dr Watson brings twenty years of vaccines expertise to the role and has broad experience in the development and licensing of vaccines for conditions such as smallpox, encephalitis and influenza.
-
NDA Group appoints Bill Griffiths as general manager, UK
systems teams as well as a specialist influenza vaccines unit.
-
Takeda appoints head of vaccines development
Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Case study
influenza vaccine.
-
Fake News is Bad for your Health
Epidemics of measles are occurring across Europe. Rates of vaccination for influenza, HPV, tetanus and polio have also declined.
-
To track disease, follow the money
The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
-
Influenza
Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.
More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
- Nucleus Global announces a trio of promotions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer introduces new logo in a ‘shift from commerce to science’
- PHE study finds people who have had COVID-19 can still transmit the virus
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
11 London
11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
